AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 64 filers reported holding AEROVATE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,310,542 | +13.9% | 44,320 | -12.9% | 0.01% | -14.3% |
| Q4 2023 | $1,151,098 | +166725.8% | 50,866 | 0.0% | 0.01% | +40.0% |
| Q3 2023 | $690 | -20.9% | 50,866 | 0.0% | 0.01% | -16.7% |
| Q2 2023 | $872 | -15.0% | 50,866 | 0.0% | 0.01% | -14.3% |
| Q1 2023 | $1,026 | -34.4% | 50,866 | -4.6% | 0.01% | -41.7% |
| Q4 2022 | $1,563 | -99.8% | 53,340 | -5.5% | 0.01% | +71.4% |
| Q3 2022 | $936,000 | +6.1% | 56,431 | 0.0% | 0.01% | +16.7% |
| Q2 2022 | $882,000 | +240.5% | 56,431 | +300.0% | 0.01% | +200.0% |
| Q1 2022 | $259,000 | – | 14,108 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 853,330 | $10,061,000 | 4.71% |
| Atlas Venture Life Science Advisors, LLC | 3,103,879 | $36,595,000 | 3.36% |
| OUP Management Co., LLC | 603,762 | $7,118,000 | 3.21% |
| Sofinnova Investments, Inc. | 3,758,686 | $44,315,000 | 2.59% |
| RA Capital Management | 8,263,982 | $97,432,000 | 1.72% |
| Cormorant Asset Management, LP | 1,830,691 | $21,584,000 | 1.28% |
| SECTORAL ASSET MANAGEMENT INC | 282,764 | $3,334,000 | 0.50% |
| Baker Brothers Advisors | 1,831,789 | $21,597,000 | 0.10% |
| Golden State Equity Partners | 15,930 | $188,000 | 0.10% |
| Old Well Partners, LLC | 12,600 | $149,000 | 0.09% |